English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 14, 2026

Xeltis announces first commercial implant of aXess vascular access device in Europe

+ Pharmaceuticals
Patient Daily | Jul 14, 2026

Researchers explore dual drug therapy to combat obesity-driven leukemia progression

+ Pharmaceuticals
Patient Daily | Jul 14, 2026

South Korean researchers develop smart nanoparticles for targeted pancreatic cancer treatment

+ Pharmaceuticals
Patient Daily | Jul 14, 2026

Spero Therapeutics secures global rights to Innovent’s autoimmune antibody in $1.1 billion deal

+ Pharmaceuticals
Patient Daily | Jul 14, 2026

Report identifies top ten brain health breakthroughs for clinicians in 2025

+ Pharmaceuticals
Patient Daily | Jul 14, 2026

AstraZeneca secures global license for Dizal’s lung cancer drug in $1.5 billion deal

+ Pharmaceuticals
Patient Daily | Jul 14, 2026

BioSpace reviews Q2 2026 biopharma job market trends and outlook

+ Pharmaceuticals
Patient Daily | Jul 14, 2026

KAUST researchers develop wearable patch to monitor medicine levels in real time

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily